Salem Investment Counselors’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$108K Sell
1,541
-26
-2% -$1.82K ﹤0.01% 450
2025
Q1
$115K Buy
1,567
+30
+2% +$2.21K ﹤0.01% 429
2024
Q4
$101K Buy
1,537
+126
+9% +$8.26K ﹤0.01% 456
2024
Q3
$110K Buy
1,411
+36
+3% +$2.81K ﹤0.01% 443
2024
Q2
$107K Hold
1,375
﹤0.01% 433
2024
Q1
$93.2K Buy
1,375
+14
+1% +$949 ﹤0.01% 460
2023
Q4
$91.7K Hold
1,361
﹤0.01% 455
2023
Q3
$92.2K Sell
1,361
-1,506
-53% -$102K ﹤0.01% 428
2023
Q2
$205K Hold
2,867
0.01% 329
2023
Q1
$199K Sell
2,867
-1,751
-38% -$122K 0.01% 337
2022
Q4
$313K Buy
4,618
+1,755
+61% +$119K 0.01% 284
2022
Q3
$157K Sell
2,863
-313
-10% -$17.2K 0.01% 334
2022
Q2
$210K Buy
3,176
+337
+12% +$22.3K 0.01% 315
2022
Q1
$188K Hold
2,839
0.01% 346
2021
Q4
$165K Buy
2,839
+1,839
+184% +$107K 0.01% 390
2021
Q3
$60K Hold
1,000
﹤0.01% 471
2021
Q2
$60K Hold
1,000
﹤0.01% 459
2021
Q1
$50K Sell
1,000
-16
-2% -$800 ﹤0.01% 456
2020
Q4
$51K Buy
1,016
+16
+2% +$803 ﹤0.01% 424
2020
Q3
$55K Hold
1,000
﹤0.01% 362
2020
Q2
$53K Hold
1,000
﹤0.01% 360
2020
Q1
$45K Hold
1,000
﹤0.01% 356
2019
Q4
$50K Hold
1,000
﹤0.01% 376
2019
Q3
$45K Hold
1,000
﹤0.01% 377
2019
Q2
$41K Sell
1,000
-300
-23% -$12.3K ﹤0.01% 390
2019
Q1
$51K Buy
+1,300
New +$51K 0.01% 287
2018
Q4
Sell
-1,300
Closed -$51K 199
2018
Q3
$51K Hold
1,300
0.01% 287
2018
Q2
$46K Hold
1,300
﹤0.01% 297
2018
Q1
$45K Sell
1,300
-700
-35% -$24.2K 0.01% 294
2017
Q4
$69K Hold
2,000
0.01% 280
2017
Q3
$68K Buy
+2,000
New +$68K 0.01% 275
2017
Q2
Sell
-1,735
Closed -$107K 661
2017
Q1
$107K Buy
+1,735
New +$107K 0.01% 291